Candriam Equities L Oncology Fund Class SF2 Fonds
1.046,55
EUR
+6,59
EUR
+0,63
%
NAV
Werbung
Top Holdings
| Name | ISIN | Anteil |
|---|---|---|
| Eli Lilly and Co | US5324571083 | 6,34% |
| AstraZeneca PLC | GB0009895292 | 4,11% |
| Roche Holding AG | CH0012032048 | 3,94% |
| Novartis AG Registered Shares | CH0012005267 | 3,79% |
| Amgen Inc | US0311621009 | 3,05% |
| Danaher Corp | US2358511028 | 3,02% |
| Intuitive Surgical Inc | US46120E6023 | 2,87% |
| Pfizer Inc | US7170811035 | 2,79% |
| Gilead Sciences Inc | US3755581036 | 2,65% |
| Thermo Fisher Scientific Inc | US8835561023 | 2,58% |
| Sonstige | 64,86% |